Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunoglobulin-specific Prophylaxis Against Citomegalovirus Infections in Immunocompromised Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

NCT07013370 is registered in ClinicalTrials.gov with Antonello Di Paolo, M.D., Ph.D. as lead sponsor.

NCT NCT07013370
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07013370 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunoglobulin-specific Prophylaxis Against Citomegalovirus Infections in Immunocompromised Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
Lead sponsor
Antonello Di Paolo, M.D., Ph.D.
Phase
Observational
Overall status
Recruiting
Start date
June 2, 2025
Completion date
June 2, 2026
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

allogeneic hematopoietic stem cell transplantation, cytomegalovirus infections, immunoglobulin prophylaxis, transplant-related disorder